|
Market Closed -
NYSE
01:30:00 04/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.620 USD | +1.16% |
|
+0.38% | +45.56% |
| 12/08 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 12/08 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.16% | +0.38% | +12.93% | +33.67% | +45.56% | +63.75% | +32.32% | +62.73% | -56.33% | 21Cr | |
| -0.04% | -1.40% | +3.41% | +7.49% | +7.90% | +57.16% | +108.15% | +346.81% | +1,408.91% | 1,03400Cr | |
| +1.17% | +4.76% | +9.44% | +24.72% | +34.54% | +56.42% | +73.50% | +59.07% | +133.35% | 67TCr | |
| -0.58% | +0.80% | +6.16% | +19.84% | +13.88% | +22.82% | +75.58% | +133.12% | +305.82% | 46TCr | |
| +2.09% | -2.06% | +0.14% | +14.41% | +8.62% | +32.28% | +37.41% | -2.26% | +46.77% | 35TCr | |
| 0.00% | +5.36% | +5.48% | +15.68% | +19.82% | +27.40% | +46.97% | +57.51% | +68.79% | 31TCr | |
| +1.42% | +0.26% | +5.62% | -8.05% | -11.92% | -0.52% | +13.51% | +42.74% | +145.95% | 26TCr | |
| +0.29% | +1.63% | +17.22% | +31.31% | +35.69% | +56.46% | +73.00% | +96.19% | +161.60% | 24TCr | |
| -0.03% | +2.13% | -0.25% | +10.95% | -7.29% | -17.30% | -53.65% | -4.21% | +97.87% | 21TCr | |
| +1.08% | +1.59% | +15.30% | +17.23% | +23.20% | +33.83% | +97.29% | +110.14% | +96.67% | 19TCr | |
| -0.72% | +2.82% | +15.10% | +13.69% | +15.70% | +16.22% | -19.48% | -38.49% | -17.14% | 16TCr | |
| +0.22% | +1.90% | +18.53% | +30.26% | +23.07% | +40.68% | +58.92% | +181.73% | +486.65% | 14TCr | |
| +0.64% | +1.70% | +4.00% | +24.43% | +26.23% | +43.35% | +9.79% | +3.78% | +20.83% | 14TCr | |
| -1.15% | -1.31% | +2.38% | +3.74% | -7.80% | -11.44% | -22.65% | -13.18% | +8.57% | 11TCr | |
| +0.27% | +0.78% | -2.25% | +0.81% | +2.30% | +27.19% | +34.51% | +0.97% | -9.78% | 10TCr | |
| -1.02% | -3.16% | +1.96% | -9.99% | -17.37% | +3.51% | +53.37% | +53.16% | +491.40% | 7.27TCr | |
| -2.61% | -0.78% | +8.87% | +18.66% | +19.03% | +26.73% | +26.96% | +54.41% | +21.01% | 6.06TCr | |
| +0.33% | +1.77% | +4.71% | +42.19% | +33.32% | +75.99% | -3.01% | +3.93% | -48.02% | 5.63TCr | |
| +0.86% | -3.47% | -13.28% | -2.63% | -22.85% | -36.15% | +10.67% | -0.30% | +178.29% | 4.5TCr | |
| -2.32% | -2.66% | +6.27% | +11.54% | +17.33% | +95.20% | +272.15% | +286.29% | -28.50% | 4.27TCr | |
| Average | +0.07% | +0.65% | +6.09% | +15.00% | +12.95% | +30.68% | +46.27% | +71.71% | +175.63% | 23.23TCr | |
| Weighted average by Cap. | +0.23% | +0.96% | +6.27% | +14.62% | +14.13% | +36.17% | +59.55% | +122.30% | +419.35% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
